Le Lézard
Classified in: Health
Subject: SVY

United States $3.5 Billion Depyrogenated Sterile Empty Vials Market to 2025 Featuring Thermo Fisher Scientific, Gerresheimer, Schott and DWK Life Sciences


DUBLIN, Nov. 16, 2018 /PRNewswire/ --

The "U.S. Depyrogenated Sterile Empty Vials Market Size, Share & Trends Analysis Report By Product (2 ml, 5 ml, 10 ml, 20 ml), By End Use (Clinical Labs, Componding Pharmacies), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The U.S. depyrogenated sterile empty vials market size is likely to reach USD 3.5 billion by 2025, progressing at a CAGR of 5.2% during the forecast period.

Technological advancements in pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.

Rising number of clinical labs in the country is resulting in an increased number of medical and diagnostic tests. This, in turn, is fueling the demand for depyrogenated sterile empty vials. Increasing number of compounding laboratories and research institutes in the U.S. is boosting the demand for these vials in the market. Moreover, continual growth in the pharmaceutical and biotechnology industry is further projected to drive the market.

Increasing number of collaborations in order to achieve innovative packaging technology is also providing an upthrust to the market. Rising incidence of infectious & non-infectious diseases and growing number of clinical studies are translating into a greater demand for these vials. Besides this, the government is backing the promotion of pharmaceutical, medical, and biotechnological researches, which is anticipated to work in favor of the market.

Further key findings from the report suggest:

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 U.S. Depyrogenated Sterile Empty Vials Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Technological advancements
3.2.2 Growth in pharmaceutical sector
3.2.3 Growing compounding pharmacies and clinical laboratories in the U.S.
3.3 Market Restraint Analysis
3.3.1 Growing demand for other parenteral packaging alternatives
3.4 Penetration & Growth Prospect Mapping
3.5 End Use Product Adoption/ Product Penetration Analysis
3.6 Pricing Analysis by Brand
3.7 U.S. Depyrogenated Sterile Empty Vials Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.8 Industry Analysis - Porter's

Chapter 4 U.S. Depyrogenated Sterile Empty Vials Market: Product Estimates & Trend Analysis
4.1 U.S. Depyrogenated Sterile Empty Vials Market: Product Movement Analysis, 2017 & 2025
4.2 2mL Vials
4.3 5mL Vials
4.4 10mL Vials
4.5 20 ml Vials
4.6 More than 20 ml Vials

Chapter 5 U.S. Depyrogenated Sterile Empty Vials Market: End use Estimates & Trend Analysis
5.1 U.S. Depyrogenated Sterile Empty Vials Market: End use Movement Analysis, 2017 & 2025
5.2 Clinical Laboratories
5.3 Compounding Pharmacies
5.4 Other End uses

Chapter 6 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/vmwclz/united_states_3?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: